7K2U
DHODH IN COMPLEX WITH LIGAND 13
Summary for 7K2U
| Entry DOI | 10.2210/pdb7k2u/pdb |
| Descriptor | Dihydroorotate dehydrogenase (quinone), mitochondrial, FLAVIN MONONUCLEOTIDE, OROTIC ACID, ... (9 entities in total) |
| Functional Keywords | dihydroorotate dehydrogenase, dhodh, oxidoreductase, inhibitor |
| Biological source | Homo sapiens (Human) |
| Total number of polymer chains | 1 |
| Total formula weight | 41956.30 |
| Authors | Shaffer, P.L. (deposition date: 2020-09-09, release date: 2020-10-21, Last modification date: 2024-03-06) |
| Primary citation | DeRatt, L.G.,Christine Pietsch, E.,Tanner, A.,Shaffer, P.,Jacoby, E.,Wang, W.,Kazmi, F.,Zhang, X.,Attar, R.M.,Edwards, J.P.,Kuduk, S.D. A carboxylic acid isostere screen of the DHODH inhibitor Brequinar. Bioorg.Med.Chem.Lett., 30:127589-127589, 2020 Cited by PubMed Abstract: Dihydroorotate dehydrogenase (DHODH) enzymatic activity impacts many aspects critical to cell proliferation and survival. Recently, DHODH has been identified as a target for acute myeloid differentiation therapy. In preclinical models of AML, the DHODH inhibitor Brequinar (BRQ) demonstrated potent anti-leukemic activity. Herein we describe a carboxylic acid isostere study of Brequinar which revealed a more potent non-carboxylic acid derivative with improved cellular potency and good pharmacokinetic properties. PubMed: 33007394DOI: 10.1016/j.bmcl.2020.127589 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (1.73 Å) |
Structure validation
Download full validation report






